| Date Filed | Type | Description |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| Kagnoff Michael (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 12,223 shares
@ $0 |
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
4
| Kagnoff Michael (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 17,339 shares
@ $0 |
|
| 05/29/2018 |
4
| Kagnoff Michael (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 16,464 shares
@ $0 |
|
| 03/05/2018 |
4
| Kagnoff Michael (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Bought 10,000 shares
@ $4.22, valued at
$42.2k
|
|
| 11/06/2017 |
4
| Kagnoff Michael (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Bought 20,000 shares
@ $4.13, valued at
$82.6k
|
|
| 09/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/14/2016 |
4
| Kagnoff Michael (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Bought 2,500 shares
@ $4.9, valued at
$12.3k
|
|